One in three Americans is likely to be affected by a brain disorder in their lifetime. Many of these conditions, such as ...

Nearly every investor has heard the adage, "Sell in May and go away." The premise is that stock market returns are often ...

Meta, the company behind Facebook, WhatsApp, and Instagram, has closed the accounts for the first three months of the year by ...

Monday marked Day One of the the remedies phase of the Google search antitrust trial **and** the start of the second week of ...

1. Choi, Hye Duck, Lee, Seung Woo, SGLT2 Inhibitors increase hemoglobin and hematocrit levels in patients with chronic kidney disease: a systematic review and meta-analysis. J Clin Pharm Ther.

While switching from sugar may help reduce calories, there’s more to consider when it comes to artificial sweeteners.

and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials. Front Pharmacol. 2025;16:1517272. Published 2025 Mar 27.

The company announced 27 abstracts at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting ...

Health and Human Services Secretary Robert F. Kennedy has sparked widespread outrage with disparaging remarks about autism ...

An interdisciplinary research team has unveiled the world's first artificial intelligence (AI) model designed to classify both the cancer stage and risk category of thyroid cancer, achieving ...

Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for patients with hormone receptor-positive metastatic breast cancer.

In a recent investor interview, Diamyd Medical Board Member Professor Mark Atkinson and CEO Ulf Hannelius shared key insights into the Company's positioning as a first-mover in precision ...